Facebook and Napster billionaire Sean Parker has seen his Institute for Cancer Immunotherapy join forces with the Cancer Research Institute (CRI) to work on boosting personalized medicine.
Sean Parker’s I/O group teams up with CRI for cancer neoantigens R&D deal
My Health eNews
- Choose the news you want from more than two dozen topics.
- Medically-reviewed health news drawn from 350+ sources, delivered monthly to your inbox.
- Your username and password ensure your personalized news is delivered only to you.